Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Black Diamond Therapeutics Inc (NASDAQ: BDTX) closed at $3.33 down -3.20% from its previous closing price of $3.44. In other words, the price has decreased by -$3.20 from its previous closing price. On the day, 1.31 million shares were traded. BDTX stock price reached its highest trading level at $3.45 during the session, while it also had its lowest trading level at $3.295.
Ratios:
For a deeper understanding of Black Diamond Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.87 and its Current Ratio is at 6.87. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on July 31, 2024, initiated with a Outperform rating and assigned the stock a target price of $20.
Stifel Upgraded its Hold to Buy on June 30, 2023, whereas the target price for the stock was revised from $2 to $10.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 28 ’24 when Versant Venture Capital VI, L. sold 221,600 shares for $6.32 per share. The transaction valued at 1,400,556 led to the insider holds 3,726,341 shares of the business.
David Epstein bought 50,000 shares of BDTX for $310,000 on Jul 31 ’24. On Jul 26 ’24, another insider, David Epstein, who serves as the Former Employee of the company, bought 50,000 shares for $6.20 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 188161312 and an Enterprise Value of 88972304.
Stock Price History:
Over the past 52 weeks, BDTX has reached a high of $7.66, while it has fallen to a 52-week low of $1.62. The 50-Day Moving Average of the stock is -34.32%, while the 200-Day Moving Average is calculated to be -31.64%.
Shares Statistics:
For the past three months, BDTX has traded an average of 1.13M shares per day and 968100 over the past ten days. A total of 51.65M shares are outstanding, with a floating share count of 43.06M. Insiders hold about 23.80% of the company’s shares, while institutions hold 72.11% stake in the company. Shares short for BDTX as of 1727654400 were 6906813 with a Short Ratio of 6.13, compared to 1724976000 on 6071354. Therefore, it implies a Short% of Shares Outstanding of 6906813 and a Short% of Float of 20.59.
